期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy 被引量:10
1
作者 Cheng-Wu Zhang Chang-Wei Dou +4 位作者 Xin-Long Zhang xi-qiang liu Dong-Shen Huang Zhi-Ming Hu Jie liu 《World Journal of Gastroenterology》 SCIE CAS 2020年第30期4489-4500,共12页
BACKGROUND Sequential transarterial chemoembolization(TACE)and portal vein embolization(PVE)are associated with long time interval that can allow tumor growth and nullify treatments'benefits.AIM To evaluate the ef... BACKGROUND Sequential transarterial chemoembolization(TACE)and portal vein embolization(PVE)are associated with long time interval that can allow tumor growth and nullify treatments'benefits.AIM To evaluate the effect of simultaneous TACE and PVE for patients with large hepatocellular carcinoma(HCC)prior to elective major hepatectomy.METHODS Fifty-one patients with large HCC who underwent PVE combined with or without TACE prior to hepatectomy were included in this study,with 13 patients in the simultaneous TACE+PVE group,17 patients in the sequential TACE+PVE group,and 21 patients in the PVE-only group.The outcomes of the procedures were compared and analyzed.RESULTS All patients underwent embolization.The mean interval from embolization to surgery,the kinetic growth rate of the future liver remnant(FLR),the degree of tumor size reduction,and complete tumor necrosis were significantly better in the simultaneous TACE+PVE group than in the other groups.Although the patients in the simultaneous TACE+PVE group had a higher transaminase levels after PVE and TACE,they recovered to comparable levels with the other two groups before surgery.The intraoperative course and the complication and mortality rates were similar among the three groups.The overall survival and disease-free survival were higher in the simultaneous TACE+PVE group than in the other two groups.CONCLUSION Simultaneous TACE and PVE is a safe and effective approach to increase FLR volume for patients with large HCC before major hepatectomy. 展开更多
关键词 Transcatheter arterial chemoembolization Portal vein embolization Major hepatectomy Hepatocellular carcinoma Future liver remnant
下载PDF
Clinical operational tolerance in liver transplantation:state-of-the-art perspective and future prospects 被引量:9
2
作者 xi-qiang liu Zhi-Qiu Hu +1 位作者 Yao-Fei Pei Ran Tao 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2013年第1期12-33,共22页
BACKGROUND:Liver transplantation is the definite treatment for end-stage liver diseases with satisfactory results.However,untoward effects of life-long immunosuppression prevent the development of alternative strategi... BACKGROUND:Liver transplantation is the definite treatment for end-stage liver diseases with satisfactory results.However,untoward effects of life-long immunosuppression prevent the development of alternative strategies to achieve better longterm outcome.Achieving clinical operational tolerance is the ultimate goal.DATA SOURCES:A PubMed and Google Scholar search using terms:"immune tolerance","liver transplantation","clinical trial","operational tolerance" and "immunosuppression withdrawal" was performed,and relevant articles published in English in the past decade were reviewed.Full-text publications relevant to the field were selected and relevant articles from reference lists were also included.Priority was given to those articles which are relevant to the review.RESULTS:Because of the inherent tolerogenic property,around 20%-30% of liver transplantation recipients develop spontaneous operational tolerance after immunosuppression withdrawal,and the percentage may be even higher in pediatric living donor liver transplantation recipients.Several natural killer and γδT cell related markers have been identified to be associated with the tolerant state in liver transplantation patients.Despite the progress,clinical operational tolerance is still rare in liver transplantation.Reprogramming the recipient immune system by creating chimerism and regulatory cell therapies is among newer promising means to achieve clinical liver transplantation tolerance in the future.CONCLUSION:Although clinical operational tolerance is still rare in liver transplantation recipients,ongoing basic research and collaborative clinical trials may help to decipher the mystery of transplantation tolerance and extend the potential benefits of drug withdrawal to an increasing number of patients in a more predictable fashion. 展开更多
关键词 immune tolerance liver transplantation clinical trial
下载PDF
New Explicit Solutions of the Generalized (2 + 1)-Dimensional Zakharov-Kuznetsov Equation 被引量:3
3
作者 Gang-Wei Wang xi-qiang liu Ying-Yuan Zhang 《Applied Mathematics》 2012年第6期523-527,共5页
his paper studies the generalized (2 + 1)-dimensional Zakharov-Kuznetsov equation using the (G'/G)-expand method, we obtain many new explicit solutions of the generalized (2 + 1)-dimensional Zakharov-Kuznetsov equ... his paper studies the generalized (2 + 1)-dimensional Zakharov-Kuznetsov equation using the (G'/G)-expand method, we obtain many new explicit solutions of the generalized (2 + 1)-dimensional Zakharov-Kuznetsov equation, which include hyperbolic function solutions, trigonometric function solutions and rational function solutions and so on. 展开更多
关键词 Zakharov-Kuznetsov Equation The (G'/G)-Expand Method HOMOGENEOUS BALANCE Principle EXPLICIT Solutions
下载PDF
Explicit Peaked Wave Solutions to the Generalized Camassa-Holm Equation 被引量:2
4
作者 Zhen-hui Xu xi-qiang liu 《Acta Mathematicae Applicatae Sinica》 SCIE CSCD 2010年第2期277-282,共6页
By constructing auxiliary differential equations, we obtain peaked solitary wave solutions of the generalized Camassa-Holm equation, including periodic cusp waves expressed in terms of elliptic functions.
关键词 The generalized Camassa-Holm equation periodic cusp wave explicit peaked wave solution
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部